secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2024-04-09T23:59:59+00:00
Accession:  0000950170-24-043030
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix raises $1M in registered direct offering at $0.375/share, with option for up to $3.9M
--------------------------------------------------------------------------------

- Issued 2,666,667 ordinary shares at $0.375 each for gross proceeds of approximately $1.0 million.
- Investor has option until April 17, 2024 to purchase up to 7,811,696 additional shares at same price, potentially raising $3.9M total.
- Initial closing expected April 11, 2024; subsequent tranche closing by April 19, 2024 if option exercised.
- Offering made under effective shelf registration statement on Form S-3 (File No. 333-274733).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024043030/0000950170-24-043030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017024043030/rnlx-20240405.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-043030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer